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ABSTRAC'l' 
Behavior is under the control of external and internal 
stimuli. The emis sion of behavior is therefore most efficient 
when the stimulus-conditions similar to those under which the 
behavior was acquired are reinstated. Amphetamine was shown 
to produce a "stimulus-state" which controlled behavior. A 
decrement in response strength occurred when a response acquired 
under the influence of amphetamine was emitted in the absence 
of amphetamine or in the presence of no-drug. The response 
strength recovered when the amphetamine-state was reinstated. 
Rats were trained to jump to a wooden platform from an 
electrifiable grid-floor, in order to avoid shock. A buzzer 
was used as the conditioned stimulus. Seven days were allowed 
to elapse between testing and training. A conditioned avoid-
ance response acquired under the influence of amphetamine was 
emitted without decrement under 1) 2.0 mg amphetamine per kg 
body weight, 2) 100 or 400 mg dl-3,4-dihydroxyphenylalanine 
per kg body weight, 3) 50 mg dl- (;~ -methyl-p-tyrosine per kg 
body weight, 100 or 400 mg dl-3,4-dihydroxyphenylalaninc per 
kg body weight and 2.0 mg amphetamine per kg body weight, 4) 
-iii-
316 mg parachloro~1enylalanine per kg body weight, 75 mg dl-5-
hydroxytryptophan per kg body wcj 0Jit and 2. 0 mg c.1mplletaminc 
per kg body weight. 
However, the per cent avoidance deteriorated markedly 
(all comparisons were statistically significant), when subjects 
trained under amphetamine were tested after pretreatment under 
1) no injections, 2) dl-C!-methyl-p-tyrosine and amphetamine, 
3) parachlorophenylalanine and amphetamine, 4) hydroxyampheta-
mine (10 mg/kg or 30 mg/kg), 5) chlorpromazine (1 or 4 mg/kg) 
and amphetamine, 6) cyproheptadine (10 mg/kg) and amphetamine. 
Moreover, animals treated chronicc1lly with amphetamine, when 
trained under amphetamine, showed a decrement in response-
strength when tested under no-drug. 
A conditioned-avoidance response acquired under the influ-
ence of hydroxyamphetarnine (30 mg/kg) was emitted without 
decrement in response strength under either hydroxyamphetamine 
or no-drug. Further, a conditioned avoidance response acquired 
under the influence of rJ.-methyl-p-tyrosine and amphetamine 
was emitted without decrement in response strength under either 
c,~-methyl-p-tyrosine and amphetamine or just amphetamine. 
These studies suggest that there exists a stimulus-stat e 
associated with amphetamine and that this behnvior-controlling 
-iv-
state is not the result of the f:t imulant property of the c1ru9. 
The drug-interaction stuJic·~; !'";uggc.sl thcil ccnlr<il. catc-
chol~mines and 5-hydroxytryptamine are involved in the am~1et­
arnine-state. Further, by varying the concentration of either 
amine, the amphetamine-state may be altered. 
-v-
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I. INTRODUCTION 
Recent experiments have demonstrated that drugs, acting 
on the brain, may also serve as discriminative stimuli. A 
rat may learn to make a certain choice in a maze if it is 
injected with one drug and a second choice if it is tested 
with no drug (Overton, 1964, 1966). The learning associated 
with a drug-state may have important implications to humans. 
New behaviors, acquired via behavior modification, under the 
influence of a drug may not be reproduced without benefit of 
the drug. 
Amphetamine, which has recently been shown to produce 
state-dependent learning (Lal, 1969), has been shown to release 
central norepinephrine (Glowinski et al., 1966b; Carr and 
Moore, 1969) and 5-hydroxytryptamine (Beauvallet et al., 1969). 
Moreover, 5-hydroxytryptophan, a precursor of 5-hydroxytrypt-
amine, has also been shown to cause a release of norepinephrine 
in vivo (Brodie et al., 1966) and in vitr~ (Carlsson et al., 
1963). In addition, recent evidence indicates that 5-hydroxy-
tryptamine acting through norepinephrine may be responsible 
for raising the thre shold necessary for shoe}: induced fighting 
(Lal et al. , 1969). 
5 
The present invcstigution sought evidence to establish: 
1) A behavioral ccntrolling am~1etamine-state in rats using 
a learning criterion which is weaker than that used 
previously in mice. 
2) That the learning associated with the amphetamine-state 
is not the result of either the stimulant property of the 
drug or the novelty of the drug stimulus. 
3) That the amphetamine-state is due to a central action of 
amphetamine. 
4) The role or roles of norepinephrine and/or 5-hydroxytrypt-
amine in the amphetamine-st ate. 
5) Whether hydroxyamphetamine, a drug which has only peripheral 
actions (Innes and Nickerson, 1965) produces state-dependent 
le~rning. 
II. LITEI<ATURE SURVEY 
Learning As~ociated with a Drug-State. 
Learning associated with a drug-state has been demonstrated 
in a number of procedures. 
Utilizing pole-climbing avoidance, Otis (1964) demonstrated 
that chlorpromazine-trained animals showed a decrement in 
avoidance when tested with saline but not with chlorpromazine. 
Similarly, saline-trained animals showed a decrement in avoid-
ance when tested with chlorpromazine but not with saline. 
Utilizing pit avoidance, Lal (1969) demonstrated that 
amphetamine-trained animals showed a decrement in avoidance 
if tested with either chlorpromazine or saline . Similarly, 
chlorpromazine trained animals showed a decrement in avoidance 
when tested with either amphetamine or saline. 
Overton (1964), utilizing at-maze, demonstrated that 
phenobarbital-trained animals showed a decrement in responding 
when te sted under no-drug. He also demonstrated response 
control in at-maze using pentobarbital and no-drug (19 64), 
pentobarbital and saline (1964), phenobarbital 0nd saline (=.)60), 
atropine and saline (1966), and chlorprom~tzine and phenobarbital 
(1966). However, he could not obtain response control under 
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either gallamine or tetraethylammonium and saline (1964). 
These latter results indicate that the response control by 
the barbiturates was not due to either muscle flaccidity or 
an autonomic blockade. 
Utilizing a two-operant schedule, one under the control 
of positive reinforcement of food and the other under the 
control of shock avoidance, Kubena and Barry (1969) demon-
strated that rats would elicit the same response for high 
doses of alcohol, pentobarbital, chlordiazepoxide and chloral 
hydrate in each procedure. 
Utilizing a schedule of positive reinforcement, Belleville 
(1964) demonstrated that rats trained to bar-press for food 
under saline, amphetamine, or morphine made a greater number 
of responses during extinction, if they received the same drug 
that was administered during acquisition. Roffman and Lal 
(1969)demonstrated that rats, trained to bar-press for water, 
would make a greater number of responses during the second 
session of extinction if they had amphetamine on the first 
extinction session. 
Learning associated with a drug-state can thus be demon-
strated by the use of either positive or negat ive reinforcer·ant . 
Further, stimulants and depre ssants, neurona l blockers and 
narcotic analgesics are some of the classes of drugs that 
produce state-dependent learning. 
Relationship Between l\mphetami~e a!1d Noreoinephr ine 
Amphetamine , which has recently been demonstrated to 
cause a decrease in the level of brain norepinephrine in 
fighting mice {Welch and Welch, 19 67 ), has been shown to 
cause a striking elevation in the level of plasma catechol-
amines (Harvey et al., 1968). Moreover, after the injection 
of H3-norepinephrine into the lateral cerebral ventricle of 
cats, Carr and Moore (1969) noted that the addition of d-
amphetamine to the venlricle perfusion fluid caused a signi-
ficant increase in the concentration of H3-norepinephrine 
and normetanephrine in the effluent of the perfusion fluid. 
These studies indicate that norepinephrine may be involved 
in the action of amphetamine. 
Utilizing various behavioral tests, Weissman et El:_. 
(1966} noted that (~-methyl-p-tyrosine, an inhibitor of 
norepinephrine synthesis (Spector et al., 1965} antagonizes 
the hyperactivity, the sniffing-licking-gnawi ng syndrome 
and the anorexia producted by amphetamine. Since the amount 
of ~~-methyl-p-tyrosine which antagonizes the amphetamine 
stimulation had no effect o n the basal level of behavioral 
performance , Weissman proposed that newJ.y synthesized nore-
pjnephrine was essential for the action of amphetamine. How-
ever, both amphetamine and 3,4-dihydroxyphenylalanine have 
recently l.)ecn shown to reverse the behci.viora l depression of 
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a conditioned avoidance respon se caused by d-methyl-p-tyrosine 
(Moore and Rech, 1967). These results indicate that the action 
of amphetamine may be more complex than proposed by Weissman. 
Amphetamine has been shown to cause an elevation in the 
levels of H3-normetanephrine (Glowinski et al., 1966a), that 
is, prevent the reuptake of extra-neural norepinephrine by 
the nerve ending. This study suggests that amphetamine's 
action consists of blocking the reuptake into the neuron of 
released norepinephrine. 
Relationship Between Catecholamines and 5-Hydroxytryptamine 
Vogt (1954) has demonstrated that norepinephrine is 
dis tributed in the brain in a manner similar to 5-hydroxy-
tryptamine, being the highest concentration in the brain stem 
and absent from the cerebellum. The 5-hydroxytryptamine has 
been shown to release norepinephrine in vitro (Carlsson et al., 
1963). Carlsson et al. (1957) also demonstrated that 5-
hydroxytryptophan and 3,4-dihydroxyphenylalanine would reverse 
the sedative effect of reserpine greater than either of the 
drugs used above. Moreover, Brodie et al. (1966) demonstrated 
that the intravenous injection of 5-hydroxytryptophan lowered 
brain norepinephrir1e levels by 50 per cent in rats _and rabbit s 
and elicited increased motor activity, piloerection, and 
panting. Recently Lal et al. (1969) postulC'lted that 5-hydroxy-
10 
tryptamine , acting through catecl1olamines, was responsible 
for amphetamine-induced elevation of the shock level necessary 
to elicit fighting. These studies suggest the the action of 
one amine may be mediated by the other amine in the central 
nervous system. 
III. EXPERI.MEN"TAL 
Chemicals 
Chemicals used were analytical grade or equivalent. 
Hydroxyarnphetamine Sulfate, Dextroamphetarnine Sulfate and 
Chlorpromazine Hydrochloride were obtained through the courtesy 
of Smith, Kline and French Labs., Philadelphia, Pennsylvania. 
Reserpine (Serpasil Phosphate) and Syrosingopine were obtained 
through the courtesy of CIBA Pharmaceutical Company, Summit, 
New Jersey. Parachlorophenylalanine was obtained through the 
courtesy of Chas. Pfizer & Co. Inc., Groton, Connecticut. 
Cyproheptadine was obtained through the courtesy of Merck-
Sharp and Dohme Research Laboratories, West Point, Pennsylvania. 
dl-3,4-dihydroxyphenylalanine (Dopa) was obtained from 
CALBIOCHEM, Los Angeles, California and from Mann Research 
Labs., New York, New York. dl- ,l-methyl-p-tyrosine was obtained 
from Regis Chemical Company, Chicago, Illinois. The dl-5-
hydroxytryptophan was obtained from Aldrich Chemical Company, 
Cedar Knolls, New Jersey. All drugs were dissolved in distilled 
water except <il.-niethyl-p-tyros ine and dl-3, 4-dihydroxyphenyl-
a lanine, which was suspended in 0.5 per cent carboxymethyl-
cellulose, and parachlorophenylalanine, which was dissolved 
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according to the procedure of Koe and Weissman (19 66) . 
Animals 
Male and female albino rats of Sprague-Dawley strain , 
random-bred, weighing 200-400 gms., were obtained from Charles 
River Breeding Farms, Wilmington, Massachusetts. Some of the 
rats had been used in other behavioral and toxicological 
experiments prior to their use in this investigation. How-
ever, there was at least an interval of one week between other 
experiments and the training of the animals for this study. 
Conditioning and Testing 
Training consisted of placing a rat on an electrifiable 
grid floor of an aluminum chamber (8 in. x 10 in. x 9 in.) 
containing a wooden platform (4 in. x 6 in. x 2 in.). The 
conditioned stimulus (CS), a buzzer of fifty-eight decibels, 
was turned on a s soon as the rat was placed in the chamber 
and then maintained for ten seconds. Responding to the CS 
with a jump (CR) onto the wooden platform terminated t he trial. 
Failure to r espond with a conditioned response resulted in a 
continuous scrambled foot shock of one milliampere from a 
Grason-Stadler Shocker, model number El064GS. The shock was 
maintained until Cl jump to escape was made. There was a thirty 
second inter t rial interval . The learning criterion, achieved 
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in a single ses son , consisted of ~ight avoidnnce-responscs 
during ten consecutive trials. Animals which did not reach 
criterion by thirty trials were not included in the study. 
After the learning trials, the subjects were returned to home 
cages for seven days. Testing for retention occurred seven 
days after the last acquisition trial. 
The criterion for learning associated with the drug-state 
consisted of a significant decrement in responding when the 
drug or drugs, used in the retention test, produced stimulus-
conditions dissimilar to those which occurred during acquisi-
tion. 
Statistics 
All statistical tests, for groups having more than ten 
rats, were compared using the Chi-square Analysis (Snedecor 
and Cochran, 1967). Whenever, the group contained less than 
ten rats, the Exact method of significance {Goldstein, 1967) 
was used to compare P values. 
Unless otherwise stated, a comparison of the per cent 
avoidance, during performance, to the per cent avoidance of 
the next to last acquisition trial conducted seven days prior 
to performance is included in the tables. Wherever appro-
priate, within-groups comp~risons are stated in the text. 
IV. RESULTS 
Quantitation of an Amphetamine-Produced "Stimulus-State" 
In order to determine the lowest dose capable of producing 
the amphetamine-state, animals were trained with various do s es 
of amphetamine and tested seven days l<:i.ter under the same dose 
of the drug or under no-drug. 
Data summarized in Table I indicate that animals traine d 
under 0 (ND-ND), 0.5 (A_ 5-A_ 5 ) or 1.0 (A 1 _0-A 1 _0 ) mg amphet-
amine per kg body weight showed a significant decrement in 
avoidance when tested under the same dose of drug. No differ-
ence in per cent avoidance during performance is seen if no-
drug-trained and no-drug-tested (ND-ND) anima ls are compared 
to animals trained and tested under 0.5 mg or 1.0 mg amphet-
amine per kg body weight (ND-ND vs A -A 5 or A1 0-A 1 , 0.5 0. . .o 
P )' . 05) . Animals trained under 2. 0 mg amphetamine per kg body 
weight showed no decrement in avoidance when tested under 
a similar dose of the drug, (A -A ) 2.0 2.0 . However, these 
animals showed a decrement in avoida nce when tested under no-
drug, (A -ND). 
2.0 
No-drug-tra ine d animals showed no dec rement 
in avoidance when te s ted under 2.0 mg amphe ta mi ne per kg body 
weight, (!\TD-A 2 _0 ). Perform;1nce of these a n ima ls was signifi-
1 5 
cantly higher than the perforn101nce of the animals trained 
under 2.0 mg amphetamine per kg body weight and tested under 
no-drug, (ND-A vs A2 -ND, P ( .05). 2. 0 . 0 
In order to determine the number of tests which could 
be performed prior to extinct ion of avoidance resp~nse, 
amphetamine-trained animals were given repeated tests under 
amphetamine or no-drug. Similarly, no-drug-trained animals 
were given repeated tests under no-drug and amphetamine. 
Amphetamine-trained animals showed significantly higher 
avoidance in all four tests than either amphetamine-trained 
animals tested under no-drug or no-drug-trained animals tested 
under no-drug, (Figure 1 A-A vs A-ND P (. 01 · A-A 
I 1-4 1-4 I I 1-4 
vs ND-ND
1
_
4
, P <C.05). No-drug-trained animals tested under 
no-drug demonstrated significantly higher avoidance in three 
of the four tests than amphetamine-trained animals did when 
tested under no-drug {ND-ND vs A-ND , P cf! • 01). 
1,3,4 1,3,4 
Testing amphetamine-trained animals under amphetamine, resulted 
in similar avoidance during the first three tests as did the 
no-drug-trained animals tested under amphetamine, (Figure 1, 
A-A 1 2 3 vs ND-A , P ~ .05). However, during the last test I I 1,2,3 
tria 1 the subjects trained and tes.ted under amphetamine showed 
significantly lower avoidance than those trained under no-drug 
but tested under amphetamine, (A-A vs ND-A , P ...- .05). 4 4 ~ 
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Figure 1 The Effect of Amphetamine on the Acquisition and 
Performance of a Conditioned Avoidance Response. 
Open Circles Represent Meuns Wnich are Significantly 
Different (ut leust at P ~ .05 level) FrLln the 
Corresponding No-Drug Controls. 
TABLE I 
EFFECT OF AMPHETAMINE ON PERFORMANCE OF CONDITIONED AVOIDANCE RESPONSES 
Drug~ (mg/kg) 1 % p 
Group Acquisition Performance N Avoidance Acquisition vs Performance 
A -A Amphetamine 0.5 Amphetamine 0.5 14 27 ~ .01 
.5 . 5 
A -A 1.0 1.0 AMphetamine 1.0 Amphetamine 1.0 15 40 ~- 01 2 
A -A Amphetamine 2. 0 Amphetamine 2.0 15 80 N oS. 
2.0 2.0 
A -A Amphetamine 2.0 Amphetamine 1.0 14 27 ~. 01 
2.0 1.0 
A 
2.0 
-0.TD Amphetamine 2.0 No Drug 
-
28 36 4'.. 05 
ND-A No Drug - Amphetamine 2.0 10 90 N .S. 
2.0 
ND-ND No Drug - No Drug - 39 55 N.S. 
1 30 min. i •P • I prior to performance. 
2 
93% avoida nce during last acquisition trial. f-' 
'1 
18 
Amphetamine-trained animals, which were given four tests 
under amphetamine (Table II, A-A ) and did not show any 
1-4 
decrement in avoidance, showed a significant decrement on 
the first no-drug test (Table II, A-ND ) . 
1 
No-drug-trained 
animals, which showed no decrement in avoidance in any of the 
four amphetamine tests (Table III, ND-A ), showed a decre-
1-4 
ment in avoidance on the first no-drug test (Table III, ND-ND 1 ). 
Per cent avoidance of no-drug-trained animals, when tested 
under amphetamine on the first drug-test, was not significantly 
different from the performance under amphetamine on the second, 
third or fourth drug-test (ND-A 1 vs ND-A 2 , ND-A 3 or ND-A 4 , 
P ~ . 05) . Similarly, performance of no-drug-trained animals, 
tested under no-drug on the fir s t drug-test, did not differ 
from similarly trained animals, te sted under no-drug on the 
second, third, or fourth test (ND-ND1 vs ND-ND 2 , ND-ND3 or 
ND-ND4 , P > .05). In addit ion no significant difference in 
per cent avoidance is seen when amphetamine-trained animals, 
tested under amphetamine on the fir s t drug-test, are compared 
to similarly trained anima l s tested under amphetamine on the 
second, third and fourth drug test (A-A vs A-A A-A or 1 2' 3 
A-J\
4
, P :;it .05). While no further deteriorc1tion in performc-:1.~e 
was seen when amphetamine-trnined animals are tested under 
no-drug on the fir st and on the second drug-test (A-ND vs 
1 
Group 
A-ND 1 A-A 1 
A-1\TD 
A-A 2 
1 
A-ND 
A-A 3 3 
A-ND 
A-A 4 
4 
1 
2.0 mg/kg, 
2 2.0 mg/kg, 
TABLE II 
EFFECT OF AMPHETAMINE ON CONSECUTIVE CONDITIONED AVOIDANCE 
RESPONSES ACQUIRED UNDER AMPHETAMINEl 
Treatment Prior to 
Performance 
No Drug 
Amphetamine 2 
No Drug 2 Amphetamine 
No Drug 
Amphetamine 2 
No Drug 2 Amphetamine 
N 
TEST l 
28 
18 
TEST 2 
8 
18 
TEST 3 
10 
33 
TEST 4 
14 
10 
% 
Avoidance 
36 
88 
37 
78 
0 
76 
0 
60 
i •P• I 30 min prior to acquisition trials. 
i •P •I 30 min prior to performance tests. 
k11 11 
p 
Acquisition vs Performance 
,.01 
N. S. 
~. 01 
N. S. 
~.01 
N .S. 
"· 01 N .S. 
~ 
1.0 
Group 
!\TD-ND 
ND-A l 
1 
ND-ND 
ND-A 2 
2 
I:\TD-ND 
l'ill-A 3 
3 
I\1:>-~1D 4 
!\TD-A 4 
1 
2.0 mg/kg, 
TABLE III 
EFFECT OF AMPHETAMINE ON CONSECUTIVE CONDITIONED AVOIDANCE 
RESPONSES ACQUIRED UNDER NO DRUG 
Treatment Prior to 
Performance 
No Drug 
Amphetamine 1 
No Drug 1 Amphetamine 
No Drug 1 Amphetamine 
No Drug 
Amphetamine 
N 
TEST 1 
39 
10 
TEST 2 
19 
37 
TEST 3 
27 
17 
TEST 4 
27 
17 
i .p. , 30 min prior to performance. 
% 
Avoidance 
55 
90 
37 
79 
41 
82 
22 
78 
p 
Acquisition vs Performance 
". 05 
2 
N.S. 
L.01 2 
N .S. 
£.01 3 
N. S. 
~- 01 3 
N. S. 
2 95% avoidc,nce during next to last acquisition trial. 
393% avoidance during next to last acquisition trial. 
N 
0 
21 
A-ND2 , P r .05), a significant difference W<lS seen when 
amphetami ne-trained animals, tcslcd under no-drug on the first 
drug-test, are compared to similarly trained animals, tested 
under no-drug on the third and on the fourth drug tests (A-ND1 
vs A-ND I A-ND I p ~ .05). 3 4 c,,.. 
Localization of Stimulus-State 
In order to determine whether the amphetamine-state is 
due to the peripheral or central effects of amphetamine, 
hydroxyamphetamine was used. Hydroxyamphetamine is an amphet-
amine-like drug which does not penetrate the central nervous 
system (Innes and Nickerson, 1965). Data presented in Table 
IV show that animals trained and tested under 10 mg hydroxy-
amphetamine per kg body weight showed a decrement in avoidance 
(OHA -OHA ) . However, testing animals trained under 30 mg 
10 10 
hydroxyamphetamine per kg body weight under either a similar 
dose of the drug or no-drug resulted in no decrement in 
avoidance. On the other hand, amphetamine-trained animals 
showed a decrement in avoidance when tested under either dos e 
of hydroxyamphetamine. 
Role of Amphetamine's Stimulant Propert:t_ 
If animals, tested under amphetamine, were emitting higher 
avoidance due to the stimulotory property of amp"!letamine, then 
anim~ls trained to a weaker criteria should demonst~ate 
TABLE IV 
EFFECT OF HYDROXYAMPHETAMINE ON CONDITIONED AVOIDANCE RESPONSES 
ACQUIRED UNDER HYDROXYAMPHETAMINE OR AMPHETAMINE 
Drug(mg/kg)l % p 
Group Acquisition Performance N Avoidance Acquisition vs Performance 
A-A Amphetamine 2 Amphetamine 2 8 88 N. S. 
:t\1D-ND No Drug - No Drug 2 39 55 £ .o5 2 
A-OHAlO Amphetamine 2 Hydroxy- 10 10 20 l-01 
amphetamine 
A-OI-LA Amphet;:imine 2 Hydroxy- 30 12 8 !. 01 30 amphetamine 
OHA - Hydroxy- 10 Hydroxy- 10 12 50 l .05 
OHAlO amphetamine amphetamine 
10 
OI-it-\ - Hydroxy- 30 Hydroxy- 30 9 88 N .S. 
OH.i\ 30 amphetamine amphetamine 
30 
O.HA 30- Hydroxy- 30 No Drug - 9 66 N.S. 
~11) amphetamine 
130 min prior to performance. 
2 
95% avoid~Dce during last acquisition trial. 
,i I 
IV 
N 
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amphetamine-induced improvemcn t in performc:rnce. A s ig!L:. f ica nl 
improvement in per cent avoidance should occur in ani. m~ls 
trained to either criteria when no-drug-trc:iined animals are 
tested under amphetamine. The data summarized in Table V 
indicate that animals trained to a weaker criteria di.d not 
show an improvement in avoidance when tested under amphetamine. 
Animals trained to the stronger criteria under no-drug showed 
a decrement in avoidance, when tested under either dl-3,4-
dihydroxyphenylalanine or no drug. However , these animals 
showed no decrement in avoidance when tested under amphetamine. 
No difference, in per cent avoidance, is seen between animals, 
trained to the weaker criteria and tested under amphetamine 
and those tested under no-drug. A significant difference in 
per cent avoidance is seen between animals, trained to a 
stronger criteria and tested under amphetamine, and those 
tested under no-drug or dl-3,4-dihydroxyphenylalanine. 
In order to determine if avoidance was due to random 
jumping off the grid, due to the central nervous system 
stimulatory effect of amphetamine, random jumping was measured. 
Data in Table VI show that amphetamine was unable to cause 
random jumping off the grid. 
Drug-St _~~1lu~_<:.'._~a Nove!:__~ric:~~ 
In orde r to determine if learning associated with the 
25 
TABLE VI 
)' 
EFFEC'I' OF AMPHETAMINE OF JUMPING OFF THE GRID BY RATS 
p 
Treatment N % Jumping Drug vs Control 
No Drug 19 0 N.S. 
Saline1 9 11 N.S. 
Amphetamine 2 131 3 
1 I 1 mg/kg, i. p., 30 min prior to trial. 
22.0 mg/kg, i.p., 30 min prior to trial. 
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amphetamine-state is due to a novel drug-stimulus, amphetamine 
was injected chronically to a group of rats. These c:tnimals, 
when trained under no-drug, did not show any decrement in per 
cent avoidance when tested under amphetamine or no-drug 
(ND -A ND-ND Table VII). A decrement in avoidance was seen c I I 
in order chronically treated animals when trained under 
amphetamine and tested under no-drug (Tab le VII, A -ND ). 
c 
Similarly treated and trained animals showed no decrement in 
avoidance when tested under amphetamine (A -A) • 
c 
Effect of Selected Drugs on Conditioned Avoidan~e Response 
Since drug-interactions will be used to determine the 
role of amines in the amphet amine -state , each drug was tested 
for its acute effects on a newly acquired conditioned 
avoidance response. Data presented in Table VIII indicate 
that animals tested under 5-hydroxytryptophan and 4.0 mg 
chlorpromazine per kg body weight caused a decrement in per 
cent avoidance of a conditioned avoidance response. Animals 
tested under reserpine, dl-3,4-dihydroxyphenyla l anine , dl-5-
hydroxytryptophan and amphetamine also showed a decrement in 
avoida nce of a conditioned avoidance response . Animals tested 
under amphetamine , reserpine, atropine, chlorprom.:izine (1.0), 
syrosingopinc , cyprohcptudine, hydroxyphenyla la nine, or dl- t·! -
methyl-p-tyrosine s~1owed no decrement in per cent avoidance. 
Group 
A -A 
c c 
A -ND 
c c 
ND -A 
c c 
ND -ND 
c c 
TABLE VII 
EFFECT OF CHRONIC AMPHETAMINE TREATMENT 1 ON CONDITIONED AVOIDANCE 
RESPONSES ACQUIRED AND TESTED UNDER AMPHETAMINE 2 
Druq 
Acquisition3 Performance 
Amphetamine Amphetamine 
Amphetamine No Drug 
No Drug Amphetamine 
No Drug No Drug 
N 
18 
18 
16 
16 
% 
Avoidance 
88 
55 
68 
68 
p 
Acquisition vs Performance 
N. S. 
t!. 05 
N.S. 
N .S. 
1 1 days prior to acquisition and during the 6 day acquisition-performance interval. 
22.0 mg/kg, i.p., 30 min prior to performance. 
3Amphetamine not administered 24 h prior to acquisition and prior to performance 
and 24 h after acquisition. 
N 
-.] 
TABLE VIII 
EFFECTS OF VARIOUS DRUGS ON A NEWLY-ACQUIRED CONDITIONED AVOIDANCE RESPONSE 
Dose % p 
Drug (mg/kg) N Avoidance Acquisition6 vs Performance 
--
At r opine l 5.0 8 75 N.S. 
'P • 2 3.0 .-eserpine 8 100 N. S . 
dl-3 , 4 -dihydr oxyphenylalani ne 3 400.0 13 93 N.S. 
01 - 5-hydroxytrypto phan 4 75.0 1 2 33 I.. 05 
Ci1lorproma zine 3 1.0 8 100 N. S. 
4.0 10 0 e. 01 
Cyproheptadine 5 10 . 0 8 100 N.S . 
d , __ c:-Methyl-p-tyrosine 6 50.0 8 100 N. S . 
SyrosingopineG 2.5 12 66 N. S. 
H;droxyamphetamine3 30.0 8 100 N. S. 
Amphetaminc3 2.0 10 70 N. S . 
N 
Roserpine + 3. 0 CD 
dl-3, 4-d:ihydroxyphenyla la nine + 400.0 8 50 L .o5 
a l·-5-hyd ox~·1...rr-itophan + 75.0 
Am;?hetamire 2.0 
---
145 min prior to performance. 
2 24 h prior to performance. 
3 30 min prior to performance. 
4 1 h prior to performance. 
5 6 0 min prior to performance. 
64 h prior to p e rformance. 
TABLE VIII (continued) 
N 
\.0 
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Role of Central and Peripheral l\rnine Stores 
If central catecholamine s and/or 5-hydroxytryptamine are 
required for the amphetamine-state to occur, than reserpine, 
a central and peripheral amine depleting drug (Pletcher et_~-, 
1955; Holzbaurer and Vogt, 1956), should prevent the resto-
ration of the amphetamine-state. Syrosingopine, ·a periphera 1 
amine depletor (Garrattini, 1959), should cause a decrement 
in amphetamine state only if peripheral amines are involved 
in the stimulus-state. Further, if only catecholamines are 
necessary for the amphetamine-state, then dl-3,4-dihydroxy-
phenylalanine, a precursor of catecholamines (Gurin and 
Delluva, 1947), should reverse the effect of reserpine. On 
the other hand, if 5-hydroxytryptamine is responsible for the 
amphetamine-state, than dl - 5-hydroxytryptophan, a precursor of 
5-hydroxytryptamine (Carlesson et al., 1963), should restore 
the amphetamine effect in reserpinized animals. If both 
norepinephrine and 5-hydroxytryptamine are needed for the 
amphetamine-state, then both dl-3,4-dihydroxyphenylalanine 
and dl-5-hydroxytryptophan will be necessary to alleviate the 
effect of reserpine. 
Data summarized in Table IX indicate that amphetamine-
treatecl animals, when tested under reserpine and amphetanine 
(A-R+A); or reserpine, dl-3,4-dihyd::-ox /phcny L:ilaninc and 
31 
amphetamine (A-R+D+A); or reserpine, dl-5-hydroxytryptophan 
and amphetamine (A-R+SHTP+A), showed a significant decrement 
in avoidance. However, testing amphetamine-trained animals 
under reserpine, dl-3,4-dihydroxyphenylalanine, dl-5-hydroxy-
tryptophan and amphetamine {A-R+D+SHTP+A) results in no decre-
ment in avoidance. Further, no decrement in per cent avoidance 
is seen when amphetamine-trained animals are tested under 
syrosingopine and amphetamine (Table IX, A-S+A). Moreover, 
a significant difference in per cent avoidance is seen when 
amphetamine-trained animal s tested under syrosingopine and 
amphetamine or reserpine, dl-3,4-dihydroxyphenylalanine, dl-
5-hydroxytryptophan , and amphetamine, are compared to similarly 
trained animals tested under reserpine and amphetamine 
(A-R+D+SHTP+A, A-S+A vs A-R+A, P L_ .01); reserpine, dl-5-
hydroxytryptophan and amphetamine (A-R+D+SHTP+A, A-S+A vs 
A-R+SHTP+A, P ~ .01); or reserpine, dl-3,4-dihydroxyphenylal-
anine and amphetamine (A-R+5HTP+D+A, A-S+A vs A-R+D+A, P ~ . 01) . 
No difference in per cent avoidance is seen when amphetamine-
trained animals tested under syrosingopine and amphetamine 
are compared to similarly trained animals tested under r es e r-
pine, dl-3,4-dihydroxyphenylalanine, dl- 5-hydroxytryp tophun 
and amphetami n e (l\-S+A vs A-R+D+5HTP+A, P ~·~ . 05) . In a ddi tion, 
no significant dif fe rence i n per cent a voidance occurs between 
Group 
!\-A 
A-R+A 
A-R+D+A 
A-R+SHTP+A 
A-R+SHTP+ 
D+A 
A-Syr+A 
TABLE IX 
EFFECT OF RESERPINE AND SYROSINGOPINE ON CONDITIONED AVOIDANCE 
RESPONSES ACQUIRED UNDER AMPHETAMINE 
Treatment Prior to 
Performance N 
Amphetamine 1 15 
Reserpine 2 + 8 
Amphetamine 
Reserpine + dl-3,4- 16 
dihydroxyphenylaline 3+ 
Amphetamine 
Reserpine + dl-5-4 24 hydroxytryptophan + 
Amphetamine 
Reserpine + dl-5- 15 
hydroxytryptophan + 
dl-3,4-dihydroxy-
phenylalanine + 
Amphetamine 
. . 5 Syros1ngop1ne + 
Amphetamine 
15 
% 
Avoidance 
80 
13 
31 
54 
66 
80 
p 
Acquisition vs Performance 
N .S. 
t .01 
,.016 
~. 05 7 
N .S. 
N.S . w IV 
TABLE IX (continued} 
12.0 mg/kg, i.p., 30 min prior to performance. 
2 3.0 mg/kg, i.p., 24 h prior to performance. 
3400 mg/kg, i.p., 15 min prior to performance. 
4 75 mg/kg, i.p., 1 h prior to performance. 
52 . 5 mg/kg, i.p., 4 h prior to performance. 
688% avoida nce during last acquisition trial. 
796% avoidance during last acquisition trial. 
w 
w 
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amphetamine-trained animals tested under reserpine, dl-3,4-
dihydroxyphcnylalanine, dl-5-hydroxytryptophan and amphet-
amine and no-drug trained animals tested under no-drug 
(A-R+D+5HT P+A vs ND-ND). The combination of reserpine and 
dl-3,4-dihydroxyphenylalanine, dl-5-hydroxytryptophan and 
amphet amine resulted in a significant decrement (Table XII, 
P ~ . 05) in avoidance in a newly acquired conditioned 
avoidance response. 
If a catecholamine, i.e. norepinephrine, released by 
amphetamine (Carr and Moore, 1969) is responsible for the 
amphetamine-stat e , than dl-3,4-dihydroxyphenylalanine should 
substitute for amphetamine. Similarly, if 5-hydroxytrypt-
amine is responsible for the amphetamine-state, than dl-5-
hydroxytryptophan should substitute for amphetamine. Data 
presented in Table X indicate that, while dl-3,4-dihydroxy-
phenylalanine subst ituted for amphetamine (A-D), a signif-
icant decrement in per cent avoidance is noted when amphet-
amine-trained animals are tested under dl-5-hydroxytryptophan, 
(A-5HTP) . 
Role of Amine Synthesis 
In order to determine if catecholamines, required for 
amphe tamine-stat8, are new] y synthesized or that which is 
stored, dl- &. -methyl-p-tyrosine, an inhibitor of catechol -
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amine synthesis (Spector et ~., 1956) was used. The time and 
dose were so selected (Rech et al., 1968) as to allow inhibi-
tion of synthesis without depletion of the stored catechol-
amines. If newly synthesized norepinephrine is needed, than 
pretreatment under dl-~-methyl-p-tyrosine should cause a 
decrement in amphetamine-trained animals tested under amphet-
amine. Replacing the catecholamines by administering dl-3,4-
dihydroxyphenylalanine should alleviate this decrement. 
Similarly, if 5-hydroxytryptamine is involved in the am~1et­
amine-state, than parachlorophenylalanine, an inhibitor of 
5-hydroxytryptamine synthesis (Koe and Weissman, 1966), 
should prevent the amphetamine-state from occuring. Replacing 
the 5-hydroxytryptamine, by administering dl-5-hydroxytryp-
tophan, should reverse the effect of parachlorophenylalanine. 
Data presented in Table X show that pretreatment with 
dl-d-methyl-p-tyrosine caused a decrement in amphetamine-
trained animals when tested under amphetamine (A-MPT+A). The 
dl-3,4-dihydroxyphenylalan ine alleviated the decrement caused 
by the dl-~-methyl-p-tyrosine. A significant difference in 
per cent avoidance is seen if amphetamine-trained animals, 
tested under amphetamine, after pretreatment under dl-d-
methyl-p-tyrosine, are compared to similarly trained animals 
tested under dl-3,4-dihydroxyphenylalanine and amphetamine 
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after pretrc<1trncnt under dl- 0 L-rncthyl-p-tyrosine (A-·MPT+A vs 
A-MPT+D~~, P ~ .01). Moreover, a significant difference 
(P .( . 05) in per cent avoidance is seen when arnphetarnine-
tra ined animals were tested under dl-3,4-dihydroxyphenylal-
anine and comp3red to amphetamine-trained animals tested under 
amphetamine and dl-C\-methyl-p-tyrosine (A-D vs A-MPT+A, P c( . 05). 
Performance of amphetamine-trained animals tested under dl-3,4-
dihydroxyphenlalanine was not significantly different from 
similarly trained animals tested under dl- t<.-methyl-p-tyrosine, 
dl-3,4-dihydroxyphenlalanine and amphetamine (A-D vs A-MPT+ 
D+A I p 7 . 0 5 ) . 
Data in Table X also indicate that parachlorophenylal--
anine caused a decrement in per cent avoidance in amphetamine-
treated animals (A-PCPA+A). However, dl-5 -hydroxytryptophan 
alleviated the decrement caused by the parachlorophenylal-
anine (A-PCPA+5HPT+A). Further, a significant difference in 
per cent avoidance is seen when amphetamine-trained animals 
were tested under parachlorophenlalanine, dl-5-hydroxytryp-
tophan and amphetamine and were compared to similarly trained 
animals but tested under either dl-5-hydroxytryptophan alone 
or parachlorophenylalanine and aml:Jhetamine (A-PCPA+5IITP+A vs 
A-5HTP or A-PCPA+A, P < .05). 
Group 
A-A 
A-MPT+A 
A-MPT+D+A 
A-D 
100 
A-D 
400 
A-PCPA+A 
A-PC PA+ 
SHTP+A 
TABLE X 
EFFECT OF P-CHLOROPHENYLALANINE AND DL-oL-METHYL-P-TYROSINE ON 
CONDITIONED AVOIDANCE RESPONSES ACQUIRED UNDER AMPHETAMINE 
Treatment Prior to % p 
Performance N Avoidance Acquisition vs Performance 
Amphetamine 1 15 80 N.S. 
dl- "-Methyl-p-tyrosine2+ 32 28 .! . 01 
Amphetamine 
dl- ~ -Methyl-p-tyrosine + 9 78 N. S. 
dl-3,4-dihydroxyphenylal-
anine 3 + Amphetamine 
dl-3,4-dihydroxyphenylal-
anine3 
12 75 N.S. 
dl-3,4-dihydroxyphenylal- 13 92 N.S. 
anine4 
Parachlorophenylalanine5+ 12 41 ~ .05 
Amphetamine 
Parachlorophenylalanine + 12 86 N .S. 
dl-5-Hydroxytryptophan 6 + 
Amphetamine w -...) 
TABLE X (continued) 
A-5HTP75 
A-5HTP150 
12.0 mg/kg, 
2 50 mg/kg, 
3100 mg/kg, 
4400 mg/kg, 
5 316 mg/kg, 
6 75 mg/kg, 
6 dl-5-Hydroxytryptophan 12 
dl-5-Hydroxytryptophan7 12 
i.p., 30 min prior to performance. 
i • p •I 2 h prior to performance. 
i •P •I 30 min prior to performance. 
i •P •I 30 min prior to performance. 
i • p • I 3 days prior to performance. 
i • p •I 30 min prior to performance. 
7150 mg/kg, i.p., 30 min prior to performance. 
8 92% avo i dance during last acquisition trial. 
" 
25 
16 
l .01 
/,. .018 
,., 
-\•: 
w 
OJ 
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Amphetamine -State A~ter I_nhibition of Catecholamine-Sy~1thcsi~ 
If animu ls arc t ra incd ancl tcs Lccl unrlcr dl- c~ -mclhy 1-p-
tyrosine and amphetamine wi t hout showing any decrement in per 
cent avoidance, than catecholamine synthesis may not be abso-
lutely necessary for the amphetamine-state. Data swnrnarized 
in Table XI indicate that animals trained under amphetamine 
after pretreatment under dl-G.{-methyl-p-tyrosine, when 
tested under amphetamine after pretreatment under dl-J-
methyl-p-tyrosine {MPT+A-MPT+A) or no pretreatment {MPT+A-A) 
showed no decrement in avoidance. Similarly trained animals, 
when tested under no-drug {A-MPT-ND), showed a decrement in 
avoidance. There was a significant difference in per cent 
avoidance {P ~ .01) between the animals trained and tes ted 
under dl- c(-methyl-p-tyrosine and amphetamine and the amphet-
amine-trained animals tested under dl-J--methyl-p-tyrosine 
and amphetamine {MPT+A-MPT+A vs A-MPT+A). 
Role of Amine Receptors 
If noradrenergic receptors are involved in the amphet-
amine-state, than chlorpromazine, a central adrenergic 
blocking agent {Douglas, 1965), should cause a decrement in 
amphetamine-state. Similarly, if serotoninergic receptors 
are involved in the am~1etamine-st ~te , than cyproheptadine, 
a serotoninergic blocking agent {Stone et_ tl·, 1961 ), should 
TABLE XI 
EFFECT OF AMPHETAMINE AND DL-~-METHYL-P-TYROSINE 
ON CONDITIONED AVOIDANCE RESPONSES 
% p 
Group Acquisition Performance N Avoidance Acquisition vs Performance 
A-A 
MPT+A-
MPT+A 
MPT+A-
A 
MPT+A-
~'D 
A-MPT+ 
A 
Amphetamine 1 
dl- / .. -Methyl-p-
tyrosine 2 + 
Amphetaminel 
dl- J.-Methyl-p-
tvrosine 2 + 
A~phetaminel 
dl-at-Methyl-p-
tyrosine 2 +1 Amphetamine 
Amphetamine 1 
Amphetaminel 
dl- / ... -Methyl-p-
tyrosine 2 + 
Amphetamine 1 
Amphetamine 1 
No Drug 
dl- ef .. -Methyl-p-
tyrosine 2 + 
Amphetaminel 
12.0 mg/kg, i.p., 30 min prior to performance. 
2so mg/kg, i.p., 2 h prior to performance. 
10 80 N. S. 
32 72 N. S. 
17 76 N .S. 
9 0 ~ .001 
32 28 ~. 01 
~ 
0 
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cause a decrement in amphetamine-state. Data presented in 
Table XII show tha t amphetamine-trained animals when tested 
under amphetamine after pretreatment with chlorpromazine 
(A-CPZ+A), cyproheptadine (A-Cyp+A), o r atropine (A-At+A) 
exhibited significant decrement in avoidance. Further, a 
significant difference (P " .01) is seen when amphetamine-
treated animals tested under amphetamine are compared to 
similarly trained animals t 8sted under a combination o f 
chlorpromazine and amphetamine (P 4'. . 01), cyproheptadine 
and amphetamine (P <!.Ol), or atropine and amphetamine 
(P ~ . 01) I (A VS CPZ+A I Cyp+A I At +A ). 
TABLE XII 
EFFECT OF CHLORPROMAZINE, CYPROHEPTADINE AND ATROPINE ON CONDITIONED 
AVOIDANCE RESPONSES ACQUIRED UNDER AMPHETAMINE 
Group 
A-A 
A-CPZ +A 
1 
A-CPZ +A 
2 
A-Cyp+A 
li.-At+A 
12.0 mg/kg, 
2 1. 0 mg/kg I 
3 4.0 mg/kg, 
4 10 mg/kg, 
5 5.0 mg/kg, 
Treatment Prior to 
Performance N 
% 
Avoidance 
1 
Amphetamine 
Chlorpromazine 2+ 
Amphetamine 
Chlorpromazine 3+ 
Amphetamine 
Cyproheptadine4+ 
Amphetamine 
Atropine5 + 
Amphetamine 
10 
14 
10 
10 
24 
i • p •I 30 min prior to performance. 
i •P •I 45 min prior to performance. 
i • p •I 45 min prior to performance. 
i.p •I 60 min prior to performance. 
i • p • I 45 min prior to performance. 
80 
36 
20 
30 
48 
690% avo·dance during last acquisition trial. 
p 
Acquisition vs Performance 
N. S. 
£.01 
~ .01 
£ .os 6 
l. . 01 
~ 
N 
V. DISCUSSION 
While animals trained under 0.5 or 1.0 mg amphetamine 
per kg body weight showed a decrement in avoidance when tested 
under corresponding doses of amphetami ne , anima ls trained and 
tested under 2.0 mg amphetamine per kg body weight showed no 
decrement in avoidance. Using the latter dose of amphetamine, 
the drug-trained anima ls showed a decrement in avoidance when 
tested under no-drug (Figure l, Table II). Thus amphetamine, 
in a dose of 2.0 mg/kg, p r oduces a stimulus-state which is 
capable of controlling avoidance behavior. The anima ls which 
are trained under no-drug and tested under no-drug in four 
consecutive daily tests showed marked decrement in avoidance 
in all of the tests (ND-ND, Tests 1 to 4, Table III). However, 
this decrement may have been due to a weaker learning since 
in a previous study, mice, trained to a stronger criterion 
under no-drug, showed no decrement in avoidance when tested 
under no-drug (Lal, 1969) . 
Since testing of no-drug trained animals under amphet-
amine resulted in no decrement in avoidance (ND-A , Table 
1-4 
III), then the stimulus-state produced by amphetamine is in 
only one direc tion, drug to no-drug. This type of stimulus 
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control has been called asymet rical <lissociiltion of learn ing 
(Overton, 1968). Berger and Stein (19 69 ) explained the 
asymetry by a neurological model. According to these workers, 
the brain is chemically differentiated into two hypothetical 
subsystems; a functionally dominant subsystem that can be 
affected by the action @f drugs and a subordinate subsys tem 
that can resist the action of these drugs. The drug treated 
animal s acquire a task in the subordinate subsystem because 
the dominant subsystem is blocked by the drug. Testing these 
animals under no-drug will result in little, if any, demon-
stration of learned behavior because the dominant subsystem 
would prevail ove r the subordinate subsystem which acted as 
a substitute. Since amphetamine has not been shown to be 
either an alpha or beta central nervous system blocking agent, 
this model does not adequately explain the asymetrical 
dissociation described in this report. The strength of the 
drug-stimulus may determine whether its stimulus control of 
behavior is symetrical or asymetrical. Lal (1969) has 
recently shown that mice, trained under no-drug, showed a 
dec rement in avoidance when tested under chlorpromazine 
while similarly trained mice showed no decrement in avoidunce 
when tested under amphetamine. However, testing chlorpro-
mazine or amphetamine-trained mice under no-drug, resulted 
45 
in a decrement in avoidance. The symctrica.l dissociation 
obtained under chlorpormazine may be due to the stronger 
stimulus-state produced by that drug, while lhe u.symetrical 
dissociation, obtained under amphetamine, is probably the 
result of a weak stimulus-state. 
The lack of decrement in animals trained under no-drug 
and tested under amphetamine (ND-.l\ , Table III) may be 
1-4 
interpreted as clue to the stimulant property of amphetamine. 
However, animals tested under a similar dose of drug, but 
trained to a weaker criteria, also showed a decrement in 
avoidance (Table V). Thus, it is unlikely that avoidance 
under amphetamine was only due to the stimulant property of 
the drug. Moreover, if the avoidance-responses were mere 
manifestations of locomotor stimulation, then animals treated 
under amph etamine would show greater number of avoidance 
r esponses on the first trial of the acquisition phase. N·'.) 
such first trial avoidances were observed (Table V). Further, 
if the amphctami!1e-s tatc did not exist then no difference in 
per c ent avo idance should exist between arnphctamine- tra ined 
animals tested under no-drug and no-drug trained animal s 
tested under no-drug (A- ND vs ND-ND). On the contr<.iry, th e re 
is a si9n ificant diffcreitce (P <"' .05) in th n:.:c out of the 
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A-ND4 vs ND-ND4
). Thus, the stimulant-state, produced by 
amphetamine, is not the result of the motor stimulant action 
o f the drug . 
If amphetamine-associated learning is due to the novelty 
of action of the drug, then by treating the animals chroni-
cally with the drug, this effect should be eliminated. In 
experiments using chronically treated amphetamine-trained 
animals , tested under amphetamine, no decrement in avoidance 
was seen (A -A ), while similarly trained animals tested under 
c 
no-drug showed a decrement in avoidance (A -1-.TD). In addition, 
c 
these animals, when trained and tested under no-drug (ND -ND) I 
c 
showed no decrement in avoidance (Table VII). The good 
avo idance seen in the latter group was probably the result of 
a greater contrast between drug and no-drug states. The 
strengthened state, ,which was due to the lack of an amphet-
amine injection, may have b een equivalent to a stronger 
training criteria. However, the lack of decrement observed 
when no-drug trained animals were tested under amphetamine 
could be due to the insufficient stimulus produced by amphet-
amine. 
Animals trained under hydroxyamphetamine, 30 mg/kg, s:1m c d 
no decrement in avoidance when tested unc1er the same dos0. of 
that drug (Table IV, OTIA -ORA ) . However, this leu.rning is 
30 30 
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associated with no apparent drug-state as there was no dccre-
rnent in response strength when hydroxyamphetamine-trained 
animals were tested under no-drug (Table IV, OHA -ND) o Since 
30 
hydroxyamphetamine, which has little central action (Innes and 
Nickerson, 1969) could not substitute for amphetamine and since 
reserpine, but not syrosingopine, caused a decrement in 
amphetamine-trained animals, then the amphetamine-state is 
central in nature and requires central amines. 
Since chlorpromazine, cyproheptadine or atropine caused 
a decrement in avoidance in amphetamine-treated animals 
(Table XII, A-CPZ+A, Cyp+A, A-At+A), then the action of cate-
cholamines, 5-hydroxytryptamine or acetylcholine may be in-
valved in the amphetamine-state. However, atropine has been 
shown to block the increase in free operant avoidance in 
amphetamine-treated animals (Goldberg and Ciolfolo, 1969). 
Thus, the decrement in avoidance in the atropinized animals 
may be the result of a direct depressant effect on the central 
nervous system by the drug. Therefore, acetylcholine may not 
be involved in the amphetamine-state. 
The dl-3,4-dihydroxyphenylalanine, which alleviated the 
decrement in avoidance produced by dl-J. -methyl-p-tyrosine 
(Table X, A-MPT+A, A-MPT+D+A) was also found to substitute 
for amphetamine(Table X, A-D). These results indicate that 
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catecholamines are invoJ ved in the amphetamine-state. However, 
animals pretreated under dl c;l-methyl-p-tyrosine and trained 
under amphetamine showed no decrement in per cent avoidance 
when tested under either amphetamine or amphetamine after 
pretreatment under dl-J...-methyl-p-tyrosine (MPT+A-A, MPT+A-
MPT+A, Table XI). Therefore, animals trained without pre-
treatment of dl- 0t-methyl-p-tyrosine are likely to utilize 
both newly synthesized as well as previously stored cate-
cholamines for release by amphetamine in their stimulus-state. 
Reduction of the catecholamines synthesis, in these animals, 
will prevent restoration of this stimulus-state . . However, in 
animals trained with reduced catecholamines synthesis, amphet-
amine probably utilized previously synthesized catecholamines 
to produce the stimulus-state. Restoration of the amphetamine-
state can occur with either greatly reduced or usual synthesis 
of catecholamines. Thus, while some released catecholamines 
seems to be essential for the amphetamine-state, the amount 
of catecholamines available for releas e, during training, may 
determine the amphetamine-state. 
The result s under 5-hydroxytryptamine seem at first somP.-
what confusing. The decrement in avoidance when amphetamir~­
trained animals are tested under amphetamine after parachloro-
phenylalanine pretreatment indicates that some indolealkyl-
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amines are involved in the amphetamine-state. Further, the 
fact that administered dl-5-hydroxytryptophan , which is taken 
up by nerve endings (Rodriguez De Lores Arnaiz and De Robertis, 
1964) and converted to 5-hydroxytryptamine (Carlsson et al., 
--
1963}, alleviated the decrement in avoidance produced by 
parachlorophenylalanine, also indicated that indolealkylamines 
are involved in the stimu lus-state (Table X, A-PCPA+A, A-
PCPA+5HTP+A). In contrast the decrement in per cent avoidance 
due to substitution of dl-5-hydroxytryptophan for amphetamine 
(A-5HTP) _indicates that indolealkylaminesmay not be involved 
in the amphetamine-stat e . However, dl-5-hydroxytryptophan 
has been demonstrated to depress shock avoidance in rats 
(Aprison and Hingtgen, 1966). Therefore , excess 5-hydroxy-
tryptamine which occurs while testing under dl-5-hydroxy-
tryptophan, probably depresses some parts of the central 
nervous system. The reason that dl-5-hydroxytryptophan is 
able to alleviate the decrement produced by parachloropheny-
lalanine is that the latter depresses 5-hydroxytryptamine 
synthesi s so that there is no excess 5-hydroxytryptamine. 
In addition, if some either substance , i.e., amphetamine, or 
catecholamines was required for the release of 5-hydroxy-
tryptamine , then in the absence of this substance, the 5-
hydroxytryptamine would remain within the nerve , and not be 
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released to produced the amphetamine-state. Since amphetamine 
has been shown to ralease 5-hydroxytryptaminc only in doses 
exceeding those used in behavioral studies (Beauvallet et al., 
1969), it is unlikely that amphetamine directly releases 5-
hydroxytryptamine. Rather, amphetamine probably releases 
catecholamines (Glowinski et al., 1966b; Carr and Moore, 1969), 
which in turn releases 5-hydroxytryptamine thereby producing 
the stimulus-state. These results are consistent with the 
findings of Lal et al., (1969), in which they hypothesized 
that 5-hydroxytryptamine acting through catecholamines is 
responsible for raising the shock level necessary for shock 
induced fighting. 
V. CONCLUSIONS 
1) Amphetamine was shown to produce an asymetric stimulus-
state which can control conditioned avoidance responses. 
2) The amphetamine-state was not based upon a novel drug 
stimulus. 
3) The amphetamine-state depended upon the central cate-
cholamines primarly norepinephrine acting through central 
serotonin. 
4) The level of available catecholamines determined the 
. 
amphetamine state. 
5) Hydroxyamphetamine did not produce a stimulus-state which 
can control behavior. 
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